Carson Wealth (CWM LLC)’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
PGA
CCA
Carson Wealth (CWM LLC)'s IDNA Position: Q2 2025 in Review
Carson Wealth (CWM LLC) sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2025, closing a stake of 1,361 shares — an estimated $28K sold.
Carson Wealth (CWM LLC) first reported a position in IDNA in Q2 2019 and held it in 15 quarters. The position peaked at $359K in Q2 2021. 47 funds tracked by Wall St. Rank hold IDNA as of Q2 2025.
- Carson Wealth (CWM LLC) reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2025 after selling out during the quarter.
- Carson Wealth (CWM LLC) sold 1,361 iShares Genomics Immunology and Healthcare ETF shares in Q2 2025, an estimated $28K.
- Carson Wealth (CWM LLC) first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2019 and held it in 15 quarters.
- Carson Wealth (CWM LLC)'s iShares Genomics Immunology and Healthcare ETF position peaked at $359K in Q2 2021.
- 47 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2025.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2025, filed 25 Jul 2025.